There have been recent cases of market withdrawal when the information, for example, originated in Australia, and that information was communicated by the manufacturer to Health Canada, and there was an agreement between the manufacturer and Health Canada to withdraw the product.
We have to realize that sometimes, as in these cases, some patients benefit from the drug. Also, when you withdraw that product from the market, you have to address issues. What are you going to do with people who really benefit from that drug because--